These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30573781)

  • 1. High cortactin expression in B-cell acute lymphoblastic leukemia is associated with increased transendothelial migration and bone marrow relapse.
    Velázquez-Avila M; Balandrán JC; Ramírez-Ramírez D; Velázquez-Avila M; Sandoval A; Felipe-López A; Nava P; Alvarado-Moreno JA; Dozal D; Prieto-Chávez JL; Schaks M; Rottner K; Dorantes-Acosta E; López-Martínez B; Schnoor M; Pelayo R
    Leukemia; 2019 Jun; 33(6):1337-1348. PubMed ID: 30573781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical indications for identical pathogenesis of isolated and non-isolated testicular relapses in acute lymphoblastic leukaemia.
    Jahnukainen K; Salmi TT; Kristinsson J; Müller J; Madsen B; Gustafsson G
    Acta Paediatr; 1998 Jun; 87(6):638-43. PubMed ID: 9686656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow-cytometric monitoring of disease-associated expression of 9-O-acetylated sialoglycoproteins in combination with known CD antigens, as an index for MRD in children with acute lymphoblastic leukaemia: a two-year longitudinal follow-up study.
    Chowdhury S; Bandyopadhyay S; Mandal C; Chandra S; Mandal C
    BMC Cancer; 2008 Feb; 8():40. PubMed ID: 18241334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of relapse-initiating cells in MLL-rearranged infant ALL by single-cell transcriptomics.
    Candelli T; Schneider P; Garrido Castro P; Jones LA; Bodewes E; Rockx-Brouwer D; Pieters R; Holstege FCP; Margaritis T; Stam RW
    Leukemia; 2022 Jan; 36(1):58-67. PubMed ID: 34304246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell functions and organ infiltration by leukemic T cells require cortactin.
    Castellanos-Martínez R; León-Vega II; Guerrero-Fonseca IM; Vargas-Robles H; Jiménez-Camacho KE; Hernández-Galicia G; Ortiz-Navarrete VF; Rottner K; Medina-Contreras O; Schnoor M
    J Leukoc Biol; 2023 Mar; 113(3):315-325. PubMed ID: 36808495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of CXCR4-mediated bone marrow colonization in CNS infiltration by T cell acute lymphoblastic leukemia.
    Jost TR; Borga C; Radaelli E; Romagnani A; Perruzza L; Omodho L; Cazzaniga G; Biondi A; Indraccolo S; Thelen M; Te Kronnie G; Grassi F
    J Leukoc Biol; 2016 Jun; 99(6):1077-87. PubMed ID: 26931577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortactin Expression is a Novel Biomarker for Risk Stratification of T-Cell Acute Lymphoblastic Leukemia.
    Aref S; Fawzy E; Darwish A; Aref M; Agdar MA
    J Pediatr Hematol Oncol; 2021 Aug; 43(6):e798-e803. PubMed ID: 33235155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of the chemokine receptor CXCR4 predicts extramedullary organ infiltration in childhood acute lymphoblastic leukaemia.
    Crazzolara R; Kreczy A; Mann G; Heitger A; Eibl G; Fink FM; Möhle R; Meister B
    Br J Haematol; 2001 Dec; 115(3):545-53. PubMed ID: 11736934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL7R is associated with CNS infiltration and relapse in pediatric B-cell precursor acute lymphoblastic leukemia.
    Alsadeq A; Lenk L; Vadakumchery A; Cousins A; Vokuhl C; Khadour A; Vogiatzi F; Seyfried F; Meyer LH; Cario G; Hobeika E; Debatin KM; Halsey C; Schrappe M; Schewe DM; Jumaa H
    Blood; 2018 Oct; 132(15):1614-1617. PubMed ID: 30154115
    [No Abstract]   [Full Text] [Related]  

  • 10. ZAP-70 as a possible prognostic factor in childhood acute lymphoblastic leukemia.
    Ebeid E; Kamel M; Moussa H; Galal U
    J Egypt Natl Canc Inst; 2008 Jun; 20(2):121-6. PubMed ID: 20029467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome after first relapse in children with acute lymphoblastic leukemia: a population-based study of 315 patients from the Nordic Society of Pediatric Hematology and Oncology (NOPHO).
    Schroeder H; Garwicz S; Kristinsson J; Siimes MA; Wesenberg F; Gustafsson G
    Med Pediatr Oncol; 1995 Nov; 25(5):372-8. PubMed ID: 7674994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
    Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring.
    Boublikova L; Kalinova M; Ryan J; Quinn F; O'Marcaigh A; Smith O; Browne P; Stary J; McCann SR; Trka J; Lawler M
    Leukemia; 2006 Feb; 20(2):254-63. PubMed ID: 16341043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCL6 modulation of acute lymphoblastic leukemia response to chemotherapy.
    Slone WL; Moses BS; Hare I; Evans R; Piktel D; Gibson LF
    Oncotarget; 2016 Apr; 7(17):23439-53. PubMed ID: 27015556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortactin Expression in Hematopoietic Cells: Implications for Hematological Malignancies.
    Castellanos-Martínez R; Jiménez-Camacho KE; Schnoor M
    Am J Pathol; 2020 May; 190(5):958-967. PubMed ID: 32084363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-27 inhibits pediatric B-acute lymphoblastic leukemia cell spreading in a preclinical model.
    Canale S; Cocco C; Frasson C; Seganfreddo E; Di Carlo E; Ognio E; Sorrentino C; Ribatti D; Zorzoli A; Basso G; Dufour C; Airoldi I
    Leukemia; 2011 Dec; 25(12):1815-24. PubMed ID: 21701492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extramedullary relapse and discordant CD19 expression between bone marrow and extramedullary sites in relapsed acute lymphoblastic leukemia after blinatumomab treatment.
    Demosthenous C; Lalayanni C; Iskas M; Douka V; Pastelli N; Anagnostopoulos A
    Curr Probl Cancer; 2019 Jun; 43(3):222-227. PubMed ID: 29895435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paucity of leukemic progenitor cells in the bone marrow of pediatric B-lineage acute lymphoblastic leukemia patients with an isolated extramedullary first relapse.
    Uckun FM; Gaynon PS; Stram DO; Sensel MG; Sarquis MB; Lazarus KH; Willoughby M
    Clin Cancer Res; 1999 Sep; 5(9):2415-20. PubMed ID: 10499612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raised blast glutathione levels are associated with an increased risk of relapse in childhood acute lymphocytic leukemia.
    Kearns PR; Pieters R; Rottier MM; Pearson AD; Hall AG
    Blood; 2001 Jan; 97(2):393-8. PubMed ID: 11154214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5T4 oncofetal antigen is expressed in high risk of relapse childhood pre-B acute lymphoblastic leukemia and is associated with a more invasive and chemotactic phenotype.
    Castro FV; McGinn OJ; Krishnan S; Marinov G; Li J; Rutkowski AJ; Elkord E; Burt DJ; Holland M; Vaghjiani R; Gallego A; Saha V; Stern PL
    Leukemia; 2012 Jul; 26(7):1487-98. PubMed ID: 22266911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.